Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion
Authors:
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (6) , 780-782
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Lipid-lowering therapy for prevention of ventricular tachyarrhythmiasJACC, 2003
- Are lipid-lowering drugs also antiarrhythmic drugs?JACC, 2003
- Statins reduce the incidence of atrial fibrillation in patients with coronary artery diseaseJACC, 2003
- Statins as Potent Antiinflammatory DrugsCirculation, 2002
- C-Reactive Protein Elevation in Patients With Atrial ArrhythmiasCirculation, 2001
- C-reactive protein and paroxysmal atrial fibrillationActa Cardiologica, 2001
- Effect of Statin Therapy on C-Reactive Protein LevelsJAMA, 2001
- Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipientsThe American Journal of Cardiology, 2001
- Atrial fibrillation impairs endothelial function of forearm vessels in humansJournal of Cardiac Failure, 2001
- Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment Is Mediated by Negative Feedback Regulation of Rho GTPase Gene TranscriptionCirculation, 2000